開設賬戶
模擬帳戶
關於我們
即時報價及新聞
市場分析
財經日曆
每日市場分析
交易平台
下載及介紹
使用教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
繁
简
EN
客户登入
開設賬戶
模擬帳戶
繁
简
EN
客户登入
開設賬戶
模擬帳戶
關於我們
上志國際介紹
上志國際特點
即時報價及新聞
即時報價
即時新聞
市場分析
財經日曆
市場分析
交易平台
平台特點
平台教學
交易細則
各項細則
資金提存
推廣和資訊
常見問題
聯絡我們
關於我們
交易細則
貴金屬市場
交易平台
市場分析
推廣和資訊
常見問題
聯絡我們
繁
简
EN
Iranian state TV said the situation in Bandar Abbas and Qeshm has returned to normal, while explosions were still heard in the Sirik area.
2026-07-08
Iranian state TV said the situation in Bandar Abbas and Qeshm has returned to normal, while explosions were still heard in the Sirik area.
返回
其他消息
2026-07-08
Chen Guo, deputy director and chief strategist at East Money Research Institute, said a downturn in the Korean memory-chip sector would not signal the end of the global tech bull and may simply reflect intra-tech rebalancing. He said the move would not imply the end of an A-share re-rating; RMB assets still have room to be re-rated, with particularly large upside for high-quality carbon-based assets in China’s A-share market.
Chen Guo, deputy director and chief strategist at East Money Research Institute, said a downturn in the Korean memory-chip sector would not signal the end of the global tech bull and may simply reflect intra-tech rebalancing. He said the move would not imply the end of an A-share re-rating; RMB assets still have room to be re-rated, with particularly large upside for high-quality carbon-based assets in China’s A-share market.
2026-07-07
July 7 — Naohu Technology’s implantable brain–computer interface (BCI) hand motor-function compensation system, described as fully implanted, fully wireless and full-function, began a GCP registration clinical trial at Fudan University‑affiliated Huashan Hospital. The multicenter GCP trial will be run with 15 tertiary hospitals in Shanghai and other regions to evaluate safety and efficacy for compensating upper‑limb function in patients with tetraplegia from cervical spinal cord injury. The devi
July 7 — Naohu Technology’s implantable brain–computer interface (BCI) hand motor-function compensation system, described as fully implanted, fully wireless and full-function, began a GCP registration clinical trial at Fudan University‑affiliated Huashan Hospital. The multicenter GCP trial will be run with 15 tertiary hospitals in Shanghai and other regions to evaluate safety and efficacy for compensating upper‑limb function in patients with tetraplegia from cervical spinal cord injury. The device is the first subdural cortical‑surface implantable BCI to enter China’s national Class III medical device registration clinical stage, marking a key step toward scaled clinical application of BCI technology in China.
Chat with us
, powered by
LiveChat